Alejo Rodriguez-Vida

7PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 09, 2026
Uncovering the role of ETS2 in prostate cancer pathogenesis: relationship with p53 and ERG.

Laura Segalés, Nuria Juanpere, Marta Lorenzo

|Oct 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.

Aude Fléchon, Rafael Morales-Barrera, Thomas Powles

|Nov 28, 2023
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.

Laura Segalés, Nuria Juanpere, Nerea Gallarín

|May 10, 2023
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors.

Ignacio Melero, Tamara Tanos, Mariana Bustamante

|Feb 22, 2023
Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO).

Cristina Suárez, James M G Larkin, Poulam Patel

Pageof 2